Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intravascular Imaging is a private cardiovascular medical device company developing next-generation intravascular imaging systems for coronary artery disease. The company combines intravascular ultrasound (IVUS) with near-infrared fluorescence (NIRF) to provide both structural and biologic information inside coronary vessels during catheter-based procedures. Its lead product is a proprietary 3-French NIRF-IVUS catheter and associated imaging system intended to improve plaque characterization and guide percutaneous coronary intervention. The company was created in collaboration with Massachusetts General Hospital/Harvard Medical School and the Technical University of Munich to commercialize novel cardiovascular imaging technologies. Based on publicly available information, its technology appears to be in preclinical-to-early translational development rather than in late-stage clinical commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intravascular Imaging.